CR20120566A - Tratamiento de enfermedades autoinmunes - Google Patents
Tratamiento de enfermedades autoinmunesInfo
- Publication number
- CR20120566A CR20120566A CR20120566A CR20120566A CR20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A
- Authority
- CR
- Costa Rica
- Prior art keywords
- alkyl
- alkoxy
- halogen
- treatment
- autoimmune diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describe el uso de un compuesto de la fórmula I, en la cual X es O, S, SO ó SO2; R1 es halógeno, trihalogenometilo, - OH, alquilo de C1-7, alcoxi de C1-4, trifluorometoxi, fenoxi, ciclohexilmetiloxi, piridilmetoxi, cinamiloxi, naftilmetoxi, fenoximetilo,-CH2-OH, -CH2-CH2-OH, alquil(C1-4)-tio, alquil (C1-4)sulfinilo, alquil(C1- 4)sulfonilo, benciltio, acetilo, nitro o ciano, o fenilo, fenil-alquilo de C1-4 o fenil-alcoxi de C1-4 estando cada grupo fenilo de los mismos opcionalmente sustituido con halógeno, CF3, alquilo de C1-4 o alcoxi de C1-4; R2 es H, halógeno, trihalogenometilo, alcoxi de C1-4, alquilo de C1-7, fenetilo o benciloxi; R3 H, halógeno, CF3, OH, alquilo de C1-7, alcoxi de C1-4, benciloxi, fenilo o alcoxi(C1-4)-metilo; cada uno de R4 y R5.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10162079 | 2010-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20120566A true CR20120566A (es) | 2013-01-09 |
Family
ID=42199281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20120566A CR20120566A (es) | 2010-05-06 | 2012-11-06 | Tratamiento de enfermedades autoinmunes |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20130172297A1 (es) |
| EP (1) | EP2566470A1 (es) |
| JP (1) | JP2013530937A (es) |
| KR (1) | KR20130066630A (es) |
| CN (1) | CN102869353A (es) |
| AU (1) | AU2011249784B2 (es) |
| BR (1) | BR112012028190A2 (es) |
| CA (1) | CA2795394A1 (es) |
| CL (1) | CL2012003091A1 (es) |
| CR (1) | CR20120566A (es) |
| CU (1) | CU20120154A7 (es) |
| EA (1) | EA201201514A1 (es) |
| EC (1) | ECSP12012312A (es) |
| IL (1) | IL222690A0 (es) |
| MA (1) | MA34285B1 (es) |
| MX (1) | MX2012012926A (es) |
| NZ (1) | NZ603999A (es) |
| PE (1) | PE20130612A1 (es) |
| SG (1) | SG185746A1 (es) |
| TN (1) | TN2012000509A1 (es) |
| TW (1) | TW201201814A (es) |
| WO (1) | WO2011138393A1 (es) |
| ZA (1) | ZA201207710B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI519539B (zh) * | 2010-12-21 | 2016-02-01 | Kyorin Seiyaku Kk | Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof |
| US9289494B2 (en) * | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60223699T2 (de) | 2001-09-27 | 2008-10-30 | Kyorin Pharmaceutical Co., Ltd. | Diarylsulfidderivat, dessen additionssalz und immunsuppressivum |
| DE60235900D1 (de) * | 2001-09-27 | 2010-05-20 | Kyorin Seiyaku Kk | Osuppressivum |
| US7482491B2 (en) * | 2002-09-19 | 2009-01-27 | Kyorin Pharmaceutical Co., Ltd. | Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| WO2004074297A1 (ja) * | 2003-02-18 | 2004-09-02 | Kyorin Pharmaceutical Co., Ltd. | アミノホスホン酸誘導体とその付加塩及びs1p受容体調節剤 |
| US7612064B2 (en) * | 2003-05-26 | 2009-11-03 | Takeda Pharmaceutical Company Limited | Sulfopyrroles |
| PT1660449E (pt) | 2003-08-28 | 2010-01-21 | Novartis Ag | Derivados de aminopropanol |
| WO2005077939A1 (en) * | 2004-02-11 | 2005-08-25 | Basilea Pharmaceutica Ag | Substituted benzimidazoles and their use for inducing apoptosis |
| JPWO2006041015A1 (ja) * | 2004-10-12 | 2008-05-15 | 杏林製薬株式会社 | アミノアルコール誘導体とその付加塩及び免疫抑制剤 |
| GB0504544D0 (en) * | 2005-03-04 | 2005-04-13 | Novartis Ag | Organic compounds |
| MX2008003170A (es) * | 2005-09-09 | 2008-03-18 | Novartis Ag | Tratamiento de enfermedades autoinmunes. |
-
2011
- 2011-05-05 WO PCT/EP2011/057203 patent/WO2011138393A1/en active Application Filing
- 2011-05-05 SG SG2012086526A patent/SG185746A1/en unknown
- 2011-05-05 NZ NZ603999A patent/NZ603999A/en not_active IP Right Cessation
- 2011-05-05 AU AU2011249784A patent/AU2011249784B2/en not_active Ceased
- 2011-05-05 PE PE2012002122A patent/PE20130612A1/es not_active Application Discontinuation
- 2011-05-05 MX MX2012012926A patent/MX2012012926A/es not_active Application Discontinuation
- 2011-05-05 MA MA35416A patent/MA34285B1/fr unknown
- 2011-05-05 KR KR1020127031868A patent/KR20130066630A/ko not_active Application Discontinuation
- 2011-05-05 CN CN2011800224469A patent/CN102869353A/zh active Pending
- 2011-05-05 JP JP2013508502A patent/JP2013530937A/ja active Pending
- 2011-05-05 US US13/643,320 patent/US20130172297A1/en not_active Abandoned
- 2011-05-05 EP EP11723889A patent/EP2566470A1/en not_active Withdrawn
- 2011-05-05 BR BR112012028190A patent/BR112012028190A2/pt not_active IP Right Cessation
- 2011-05-05 CA CA2795394A patent/CA2795394A1/en not_active Abandoned
- 2011-05-05 EA EA201201514A patent/EA201201514A1/ru unknown
- 2011-05-05 TW TW100115816A patent/TW201201814A/zh unknown
-
2012
- 2012-10-15 ZA ZA2012/07710A patent/ZA201207710B/en unknown
- 2012-10-23 TN TNP2012000509A patent/TN2012000509A1/en unknown
- 2012-10-25 IL IL222690A patent/IL222690A0/en unknown
- 2012-11-05 CU CU2012000154A patent/CU20120154A7/es unknown
- 2012-11-06 CR CR20120566A patent/CR20120566A/es unknown
- 2012-11-06 CL CL2012003091A patent/CL2012003091A1/es unknown
- 2012-11-27 EC ECSP12012312 patent/ECSP12012312A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011249784B2 (en) | 2014-03-06 |
| CN102869353A (zh) | 2013-01-09 |
| EA201201514A1 (ru) | 2013-05-30 |
| KR20130066630A (ko) | 2013-06-20 |
| TN2012000509A1 (en) | 2014-04-01 |
| WO2011138393A1 (en) | 2011-11-10 |
| EP2566470A1 (en) | 2013-03-13 |
| SG185746A1 (en) | 2013-01-30 |
| TW201201814A (en) | 2012-01-16 |
| MA34285B1 (fr) | 2013-06-01 |
| BR112012028190A2 (pt) | 2016-08-02 |
| ECSP12012312A (es) | 2012-12-28 |
| CU20120154A7 (es) | 2013-03-27 |
| ZA201207710B (en) | 2013-06-26 |
| AU2011249784A1 (en) | 2012-12-20 |
| CA2795394A1 (en) | 2011-11-10 |
| PE20130612A1 (es) | 2013-06-06 |
| CL2012003091A1 (es) | 2013-03-22 |
| US20130172297A1 (en) | 2013-07-04 |
| MX2012012926A (es) | 2012-12-17 |
| JP2013530937A (ja) | 2013-08-01 |
| IL222690A0 (en) | 2012-12-31 |
| NZ603999A (en) | 2014-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2185191T3 (da) | Influenzavacciner med lavt indhold af tilsætningsstoffer | |
| DK2010498T3 (da) | Syntese af acylaminoalkenylenamider, der kan anvendes som substans P-antagonister | |
| DK2317851T3 (da) | Anvendelse af 5-fluorcytosin som fungicid | |
| DK3502138T3 (da) | Tavse Fc-varianter af anti-CD40-antistoffer | |
| DK2057122T3 (da) | 4-(2-amino-1-hydroxyethyl)phenol-derivater som agonister af 2-adrenerg-receptoren | |
| PE20131343A1 (es) | Derivados de acido benzoico | |
| CO6270314A2 (es) | Un derivado de y--amino acido biciclico que tiene una actividad como ligando (alfa)2(omega) | |
| UY32223A (es) | Nuevos compuestos sustituidos con halogenos | |
| DOP2009000202A (es) | Compuesto anulares fusionados como agonistas parciales de ppar-gamma | |
| DK2534233T3 (da) | Rengøringssammensætning, der omfatter amylasevarianter med høj stabilitet i nærværelse af et chelateringsmiddel | |
| DK1885684T3 (da) | Derivater af 4-(2-amoni-1-hydroxyethyl)phenol som agonister af beta-2-adrenerg receptor | |
| DK2310382T3 (da) | Amidophenoxyindazoler, der er anvendelige som hæmmere af c-met | |
| DK3111764T3 (da) | Tensider af amin-typen til styring af herbicid spraydrift | |
| EA201100037A1 (ru) | Органические соединения | |
| DK2046775T3 (da) | N-(amino-heteroaryl)-1h-indol-2-carboxamidderivater som, antagonister af receptorer af type trpv1 eller vr1 | |
| RS54375B1 (en) | TIOACETATE UNITS, COMPOSITIONS AND USE PROCEDURES | |
| DK1954690T3 (da) | Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase | |
| DK3225251T3 (da) | Modulering af pro-neurotrofinaktivitet | |
| DK1928872T3 (da) | Hidtil ukendte sulfonylpyrroler som inhibitorer af hdac | |
| EA201491153A1 (ru) | КОМПОЗИЦИИ БУПРЕНОРФИНА И АНТАГОНИСТОВ μ-ОПИОИДНЫХ РЕЦЕПТОРОВ | |
| DK2732012T5 (da) | Sammensætninger af additiver som forbedrer stabilitet og motorydelse af dieselbrændstoffer | |
| DK2421537T3 (da) | Pyrazolylaminopyridiner som inhibitorer af FAK | |
| DK2791350T3 (da) | Enzymcocktails fremstillet af blandede kulturer | |
| RS54488B1 (en) | NALOXOL-POLYETHYLENE GLYCOL CRYSTAL CONJUGATE | |
| BRPI0713314A2 (pt) | Processo para a preparação de 3-(2-hidróxi-5-fenil substituído)-n-alquil-3-fenilpropilaminas |